验证数据展示
经过测试的应用
Positive IHC detected in | mouse spleen tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Positive IF/ICC detected in | HeLa cells, HepG2 cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
84882-5-RR targets BCL3 in IHC, IF/ICC, ELISA applications and shows reactivity with human, mouse samples.
经测试应用 | IHC, IF/ICC, ELISA Application Description |
经测试反应性 | human, mouse |
免疫原 | BCL3 fusion protein Ag13375 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Recombinant |
产品类型 | Antibody |
全称 | B-cell CLL/lymphoma 3 |
别名 | Proto-oncogene BCL3, D19S37, BCL4, BCL-3, B-cell lymphoma 3 protein |
计算分子量 | 446 aa, 47 kDa |
观测分子量 | 48-60 kDa |
GenBank蛋白编号 | BC064993 |
基因名称 | BCL3 |
Gene ID (NCBI) | 602 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Protein A purfication |
UNIPROT ID | P20749 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
BCL3 (BCL3 Transcription Coactivator), as a Protein Coding gene, has seven ankyrin repeat domains, a proline-rich N terminal domain and a serine- and proline-rich C-terminal domain(PMID: 31930327). BCL3 is an important contributor to chronic inflammatory disease states, such as osteoarthritis and rheumatoid arthritis. In the cytoplasm, BCL3 inhibits the nuclear translocation of the NF-kappa-B p50 subunit. In the nucleus, BCL3 acts as transcriptional activator that promotes transcription of NF-kappa-B target genes(Uniprot).
实验方案
Product Specific Protocols | |
---|---|
IHC protocol for BCL3 antibody 84882-5-RR | Download protocol |
IF protocol for BCL3 antibody 84882-5-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |